Clinical implications of plasma Nogo-A levels in patients with coronary heart disease.

about

Clinical implications of plasma Nogo-A levels in patients with coronary heart disease.

Item

http://www.wikidata.org/entity/Q41015210

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical implications of plasma Nogo-A levels in patients with coronary heart disease.

@en

type

Item

label

Clinical implications of plasma Nogo-A levels in patients with coronary heart disease.

@en

prefLabel

Clinical implications of plasma Nogo-A levels in patients with coronary heart disease.

@en

P1476

Clinical implications of plasma Nogo-A levels in patients with coronary heart disease.

@en

P2093

Bei-Bei Gao

http://www.w3.org/2001/XMLSchema#string

Hong Li

http://www.w3.org/2001/XMLSchema#string

Jin-Yu Huang

http://www.w3.org/2001/XMLSchema#string

Lei Lai

http://www.w3.org/2001/XMLSchema#string

Liang Zhou

http://www.w3.org/2001/XMLSchema#string

Xian-Hua Ye

http://www.w3.org/2001/XMLSchema#string

Yu Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1

Identification and characterization of a novel Nogo-interacting mitochondrial protein (NIMP)

Cell death: critical control points

Proteomic-based detection of a protein cluster dysregulated during cardiovascular development identifies biomarkers of congenital heart defects

Symptom predictors of acute coronary syndromes in younger and older patients.

Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.

Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes.

Association between inflammatory biomarkers and thin-cap fibroatheroma detected by optical coherence tomography in patients with coronary heart disease.

Amino-Nogo-A antagonizes reactive oxygen species generation and protects immature primary cortical neurons from oxidative toxicity.

P304

771-777

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/AOMS.2016.58713

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28721144

http://www.w3.org/2001/XMLSchema#string

P932

5510510

http://www.w3.org/2001/XMLSchema#string